{
    "title": "Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia",
    "pmid": "35431360",
    "pmcid": "PMC8973308",
    "study_parameters": [
        {
            "Study Parameters ID": 1451769007,
            "Variant Annotation ID": 1451769000,
            "Study Type": "cohort",
            "Study Cases": 68.0,
            "Study Controls": null,
            "Characteristics": "Pediatric ALL",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1451769000"
        },
        {
            "Study Parameters ID": 1451768400,
            "Variant Annotation ID": 1451768380,
            "Study Type": "cohort",
            "Study Cases": 68.0,
            "Study Controls": null,
            "Characteristics": "Pediatric ALL",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1451768380"
        },
        {
            "Study Parameters ID": 1451769045,
            "Variant Annotation ID": 1451769040,
            "Study Type": "cohort",
            "Study Cases": 68.0,
            "Study Controls": null,
            "Characteristics": "Pediatric ALL",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": null,
            "Ratio Stat Type": null,
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1451769040"
        }
    ],
    "var_drug_ann": [
        {
            "Variant Annotation ID": 1451768380,
            "Variant/Haplotypes": "rs116855232",
            "Gene": "NUDT15",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "Dosage",
            "Significance": "no",
            "Notes": "Authors stated \"Although no statistically significant associations were identified, two of the four patients; heterozygous for NUDT15 required a decrease in 6-MP during the follow-up period. \" No TT homozygotes were observed. \"Studies with a larger population size are needed",
            "Sentence": "Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.",
            "Alleles": "CT",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Other:Acute lymphoblastic leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "PMID_norm": "35431360",
            "Variant Annotation ID_norm": "1451768380"
        },
        {
            "Variant Annotation ID": 1451769040,
            "Variant/Haplotypes": "rs1800460",
            "Gene": "TPMT",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "Dosage",
            "Significance": "no",
            "Notes": "Authors stated \"Although no statistically significant associations were identified... In the case of rs1800460, of the six heterozygous patients, three required a dosage decrease, and two were also heterozygous for rs1142345.\" No TT homozygotes were observed. \"Studies with a larger population size are needed",
            "Sentence": "Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.",
            "Alleles": "CT",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Other:Acute lymphoblastic leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "PMID_norm": "35431360",
            "Variant Annotation ID_norm": "1451769040"
        }
    ],
    "var_pheno_ann": [
        {
            "Variant Annotation ID": 1451769000,
            "Variant/Haplotypes": "rs1800462",
            "Gene": "TPMT",
            "Drug(s)": "mercaptopurine",
            "PMID": 35431360,
            "Phenotype Category": "Toxicity",
            "Significance": "no",
            "Notes": "Authors stated \"Although no statistically significant associations were identified, ...Concerning the genetic variants of TPMT, for rs1800462, two of the four heterozygous patients presented febrile neutropenia, and the same patients also required discontinuation 6-MP during the first six months of maintenance therapy.\" No GG homozygotes were observed. \"Studies with a larger population size are needed",
            "Sentence": "Genotype CG is associated with decreased likelihood of febrile neutropenia and discontinuation when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.",
            "Alleles": "CG",
            "Specialty Population": "Pediatric",
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "Side effect/efficacy/other": "likelihood of",
            "Phenotype": "Side Effect:Febrile neutropenia, Side Effect:Discontinuation",
            "Multiple phenotypes And/or": "and",
            "When treated with/exposed to/when assayed with": "when treated with",
            "Multiple drugs And/or": null,
            "Population types": "in children with",
            "Population Phenotypes or diseases": "Other:Acute lymphoblastic leukemia",
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "PMID_norm": "35431360",
            "Variant Annotation ID_norm": "1451769000"
        }
    ],
    "var_fa_ann": []
}